| 09:20-09:30 |
Opening Remark |
정명호 회장(전남의대) |
| 09:30-11:00 |
Vascular Inflammation and Remodeling |
좌장 : 김효수/서울의대, 오구택/이화여대 |
| 09:30-09:50 |
Role of Dendritic Cells in Vascular Inflammation  |
최재훈/한양대 |
| 9:50-10:10 |
Vessel Remodeling in Pulmonary Hypertension |
김종민/숙명여대 |
| 10:10-10:30 |
Vessel Remodeling in Diabetic Retinopathy |
윤창환/서울의대 |
| 10:30-10:50 |
Regulation of Atherosclerosis by Calpain Proteolytic Systems |
Takuro Miyazaki/Showa University, Japan |
| 10:50-11:00 |
Panel discussion
패널 : 박영미, 박종길, 조경현, 조현재, 한진
|
| 11:10-12:40 |
Understanding Cardiometabolic Nutrition: A Cell to Neighborhood Perspective |
좌장 : 서홍석/고려의대, 이명숙/성신여대 |
| 11:10-11:30 |
Ectopic Olfactory Receptors Regulate Cellular Lipid Metabolism and Adiposity |
이성준/고려대 |
| 11:30-11:50 |
Nutritional Systems Biology Approach for Understanding Homeostatic Protection of Botanical Phytochemicals Against Vascular Endothelial Dysfunction in Human Clinical Trials |
권오란/이화여대 |
| 11:50-12:10 |
Social Determinant and Cardiometabolic Risks: Diet as a Mediator |
김오연/동아대 |
| 12:10-12:30 |
Impact of Social Network Characteristics on Cardiometabolic Health |
김현창/연세의대 |
| 12:30-12:40 |
Panel discussion
패널 : 강현재, 김상현, 김재택, 신민정, 이상학
|
| 13:40-14:30 |
Debate Session ; Highly Intensive Lipid Lowering Therapy in DM without CVD
- CV Risk and LDL-Cholesterol Target |
좌장 : 이문규/성균관의대, 우정택/경희의대 |
| 13:40-13:50 |
Pros |
김재현/성균관의대 |
| 13:50-14:00 |
Cons |
이우제/울산의대 |
| 14:00-14:10 |
Rebuttals |
|
| 14:10-14:30 |
Panel discussion
패널 : 김현민, 김혜진, 문민경, 박형규, 홍순준
|
| 14:30-16:00 |
Always Curious Questions ; Dyslipidemia and Atherosclerosis |
좌장 : 정명호/전남의대, 신현호/제일병원 |
| 14:30-14:45 |
New Promising Lipid-Modifying Drugs |
이용호/연세의대 |
| 14:45-15:00 |
Lipid-Lowering Therapy in ESRD Patient |
장태익/국민건강보험공단 |
| 15:00-15:15 |
Management of Insignificant Arterial Stenosis |
박광열/중앙의대 |
| 15:15-15:30 |
Exercise for Cardiometabolic Health |
김영주/성신여대 |
| 15:30-15:45 |
Sleep and Cardiovascular Disease |
양광익/순천향의대 |
| 15:45-16:00 |
Panel discussion
패널 : 김용재, 김학령, 서우근, 유태현, 임영효
|
| 16:10-17:40 |
Update session ; How to Interpret Recent CV Outcome Trials and Future Perspective |
좌장 : 김치정/중앙의대, 박중열/ 울산의대 |
| 16:10-16:25 |
PCSK9 Inhibitors |
이은영/가톨릭의대 |
| 16:25-16:40 |
What Do We Get from Recent Statin and CETP Inhibitors Trials? |
김병진/성균관의대 |
| 16:40-16:55 |
How to Interpret Recent CV Outcome Trials and Future: SGLT2 Inhibitors/ DPP4 Inhibitors / GLP-1 Analogues |
정인경/경희의대 |
| 16:55-17:10 |
NOACs in atherosclerotic CV disease |
최성훈/한림의대 |
| 17:10-17:40 |
Panel discussion
패널 : 김주한, 박재형, 배지철, 이왕수, 이재혁
|
| 17:40-17:50 |
Closing remark |
김효수 이사장(서울의대) |
